Office of Research Federal and State Agency Guidance on COVID-19 - Office of Research

Federal and State Agency Guidance on COVID-19

Guidance From Federal Sponsors and Agencies

Updated 4/2/20

The following is a condensed version of important announcements from key agencies. You can find a more exhaustive list by agency here. UCOP also provides a running list of daily updates. UCOP has also released a memo on 3/24/20 titled Charging grants and contracts costs to Federal sponsored awards during COVID-19 that explains recent guidance from OMB, NIH and NSF.

California Department of Food and Agriculture

CDFA Guidance and Resource Page

Centers for Disease Control and Prevention (CDC)

Information for CDC Applicants and Recipients of CDC Funding

Department of Defense

Frequently Asked Questions for DOD Research Proposers and Awardees Impacted by the Novel Coronavirus (COVID-19) (3/24/20)

Department of Health and Human Services (DHHS)

Interim Guidance for Patients on Clinical Trials Supported by the NCI Cancer Therapy Evaluation Program and the NCI Community Oncology Research Program (3/13/20)

Food and Drug Administration (FDA)

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

National Institute of Food and Agriculture (NIFA)

National Institute of Food and Agriculture Coronavirus/COVID-19 resource page

National Institutes of Health (NIH)

Coronavirus Disease 2019 (COVID-19):  Information for NIH Applicants and Recipients (updated frequently)
Frequently Asked Questions (FAQs): COVID-19 Flexibilities for Applicants and Recipients (3/25/20)

National Science Foundation (NSF)

Impact on Existing Deadline Dates (3/27/20)
Guidance on NSF’s implementation of the Office of Management and Budget (OMB) Memorandum M-20-17 (3/23/20)
NSF Important Notice No 146 to the Community Regarding COVID-19 (3/23/20)

Office of Management and Budget (OMB)
OMB has issued a memo providing “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) (3/9/20)

Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19)  (3/20/20)

Related to COVID-19